Mechanistic role of cAMP and hepatocyte growth factor signaling in thioacetamide-induced nephrotoxicity: Unraveling the role of platelet rich plasma - 09/12/18
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | PRP improved kidney function and disturbed kidney architecture. |
• | PRP decreased MCP-1 level, caspase3 and α- SMA expression. |
• | PRP improved redox status, mitochondrial function and increased renal cAMP, beclin1 and HGF levels |
• | PRP has a reno-protective effect via cellular and molecular mechanisms. |
Abstract |
Chronic kidney diseases occur as result of exposure to wide range of deleterious agents as environmental pollutants, toxins and drug. Currently, there is no effective protective therapy against renal damage, fibrosis and its sequel of end stage renal disease. Platelet-rich plasma (PRP) has a progressively gained consideration in wound healing, repair/regeneration of damaged tissues and conservation of organ function. However, its impact on thioacetamide (TAA) induced chronic renal damage has not been elucidated yet. So, the present study was carried out to evaluate the possible protective and regenerative effect of PRP against TAA induced renal damage and their potential underlying mechanism. PRP treatment improved redox state, renal function disturbed histologicl features; decreased monocyte chemo-attractant protein-1 (MCP-1) level; increased Peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α) marker of mitochondrial biogenesis and metabolism; cyclic adenosine monophosphate (cAMP); hepatocyte growth factor (HGF) and autophagy protein beclin-1 level. In addition, PRP treatment decreased apoptosis and fibrosis as evidenced by decreased active caspase3 and α-SMA expression and immunoreactivity, respectively. In conclusion, PRP could potentially protect against TTA-induced chronic kidney damage by alleviating oxidative stress, improving, mitochondrial biogenesis, autophagy, disruption of the inflammatory, apoptotic and fibrotic response induced by TTA.
Le texte complet de cet article est disponible en PDF.Keywords : Thioacetamide, Platelet rich plasma, Cyclic adenosine monophosphate, Hepatocyte growth factor (HGF), Monocyte chemo-attractant protein-1, Peroxisome proliferator-activated receptor gamma co-activator-1??, Beclin-1
Plan
Vol 109
P. 1078-1084 - janvier 2019 Retour au numéro
Article précédent
- Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na+-d-glucose cotransporter SGLT1 in the small intestine
- Nan Wang, Shuai Li, Xiao-chen Guo, Jun-yan Li, Gui-ping Ren, De-shan Li
- MiR-217 promotes cell proliferation and osteogenic differentiation of BMSCs by targeting DKK1 in steroid-associated osteonecrosis
- Zhipeng Dai, Yi Jin, Jia Zheng, Ke Liu, Jiajun Zhao, Shanfeng Zhang, Fei Wu, Zhibo Sun
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?